Wound healing deficits in severe generalized recessive dystrophic epidermolysis bullosa along anticancer treatment with cetuximab

J Dtsch Dermatol Ges. 2019 Apr;17(4):448-450. doi: 10.1111/ddg.13802. Epub 2019 Mar 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Antineoplastic Agents, Immunological / administration & dosage
  • Carcinoma, Squamous Cell / complications*
  • Carcinoma, Squamous Cell / pathology
  • Cetuximab / administration & dosage*
  • Epidermolysis Bullosa Dystrophica / complications*
  • Epidermolysis Bullosa Dystrophica / pathology
  • Female
  • Humans
  • Skin Neoplasms / complications*
  • Skin Neoplasms / pathology
  • Wound Healing*

Substances

  • Antineoplastic Agents, Immunological
  • Cetuximab